It has been described that some individuals remain HIV uninfected despite multiple exposures to the virus [1] [2] [3] [4] . There is no clear explanation for this low susceptibility to infection and a number of probable "protective" factors have been reported. First, virus characteristics or levels of plasma viral load (PVL) have been implicated in resistance to infection [5] . Second, variants of host genes have been suggested as important determinants of susceptibility to HIV-1 infection [6] [7] [8] [9] . Finally, mucosal and systemic HIV-1-specific cellular and humoral responses could play a determining role in protection against HIV-1 infection [4, [10] [11] [12] [13] [14] [15] [16] .
from infection [18] . Other factors may influence this low susceptibility to infection.
Some authors have reported altered T cell subset distribution patterns in highly HIV-exposed, uninfected individuals, and these changes have been explained as a consequence of a broad spectrum of immunogenic challenges during viral exposure [2, 15, [19] [20] [21] [22] . Conversely, others have hypothesized that the changes in immunological parameters observed in highly exposed, HIVuninfected individuals would be a constitutive characteristic and a surrogate marker of genetic or immunological advantage implying low susceptibility to infection [23] [24] [25] .
We analyzed multiple genetic and immunological parameters in 21 heterosexual couples with discordant HIV serostatuses who had a history of penetrative sexual intercourse without condoms (and no other known risk factors). Thus, we could correlate the changes observed in the immune system with the PVL of the HIV-1-infected partner.
METHODS

Study participants.
Twenty-one serodiscordant heterosexual couples were enrolled in the study. The couples were recruited in a single center (Hospital Clínic de Barcelona, Spain); 12 were recruited when 1 of the partners was diagnosed with HIV infection, and 9 were HIV-1-serodiscordant couples seen in the healthcare center. The 21 heterosexual couples studied comprised 16 highly HIV-exposed, uninfected males and 5 highly HIV-exposed, uninfected females (table 1) . Inclusion criteria were a history of ongoing unprotected sexual intercourse for at least 12 months; 5 episodes of unprotected sexual intercourse in the last 3 months, with at least 1 episode in the 4 weeks prior to study entry; and 1 HIV-1-infected patient per couple with a PVL 13000 copies/mL. Homosexual couples and individuals with multiple partners were excluded. Twenty-two HIV-1-uninfected, low-risk individuals matched for age and gender were recruited as a control group. Serodiscordant couples were instructed to use condoms during sexual intercourse after inclusion in the study (day 0). Immunological and microbiological tests were repeated 3 months later (day 90) in 10 couples who reported condom use during all episodes of sexual intercourse during this period.
All immunological and virological analysis was performed in a blinded fashion. The study and study procedures were explained to all patients in detail, and all gave written informed consent. The study was approved by our institutional ethical review board.
Initial evaluation, sample collection, and processing. A case report form with epidemiological data and information on sexually transmitted infections (STI), sexual history (including number of partners and type of sexual intercourse), and antiretroviral medication history was used. All women had gynecological and cervicovaginal cytological examinations performed.
The following blood analyses were performed: assays for IgG anti-hepatitis C virus, HBs antigen, and HBs antibodies; venereal disease research laboratory test; fluorescent treponemal antibody absorption test ; and PVL. Vaginal cultures (women) and urethral swab cultures (men) were performed for the following: Chlamydia trachomatis, Neisseria gonorrhea, and Mycoplasma hominis. All tests were repeated at the 3-month follow-up.
PVL. Plasma HIV-1 RNA levels were determined using the Amplicor HIV-1 Monitor Ultra Sensitive Specimen Preparation Protocol Ultra Direct Assay (Roche Molecular Systems) with a quantification limit of 20 copies/mL.
Genotypic analysis of chemokine receptors. Genomic DNA was isolated from either PBMCs or whole blood (Qiagen kits; Qiagen). Polymerase chain reaction (PCR) amplification of CCR5 sequences was performed using genomic DNA extracted from cryopreserved cells. The D32 deletion in the CCR5 gene was detected by amplifying part of the coding region, with primers and reaction conditions described elsewhere [26] .
Lymphocyte subsets and lymphoproliferative response to pokeweed mitogens and HIV-1-specific antigens. Subpopulations of CD3 + , CD4 + , and CD8 + T cells were determined in blood or cervicovaginal lavage cells by 3-color flow cytometry, as described elsewhere [27] . Lymphoproliferative responses to pokeweed mitogens and HIV-1-specific antigens were determined, as described elsewhere [27] . Results were expressed as mean counts per minute (cpm). The stimulation index (SI) was calculated for each sample as counts per minute for cells with stimulus divided by counts per minute for cells without stimulus. Positive polyclonal and antigen-specific responses were defined as 13000 counts per min and SI 115 and 13, respectively. Intracellular cytokine staining. The presence of HIV-1-specific CD4 + and CD8 + T lymphocytes in blood was analyzed by measuring the intracellular interferon (IFN)-g production by flow cytometry, as described previously [28] . Mononuclear cells were stimulated with a pool of overlapping peptides from HIV-1 subtype B consensus Gag (15-mer) obtained from National Institutes of Health AIDS Research and Reference Reagents Program (cat no. 8117) for 6 h. Results were considered to be positive if intracellular IFN-g production was detected in у0.02% of cells, after subtracting background. The cutoff for positive IFN-g production determined by intracellular staining was calculated by figuring the median of the percentage of CD4 + or CD8 + CD69 + IFN-g + obtained in nonstimulated PBMCs, which were cultured with medium alone for 6 h, and after substrating the background, defined by the nonspecific binding using the different Ig isotypes conjugated with PerCP, PE, or FITC.
Specific HIV-1 CTL response. An enzyme-linked immunosorbent spot (ELISPOT) assay was used to measure HIV epitope-specific CD8 + T cell IFN-g release from cryopreserved PBMC samples, as described elsewhere [29] . A mean of 16 Measurements of HIV-1-specific antibodies in serum and cervicovaginal lavage. The presence of gp41-specific IgA in plasma samples was evaluated by ELISA, as previously described [30, 31] . Each assay was correlated with a negative control (a pool of cervicovaginal lavage fluid specimens or serum from 10 unexposed, healthy control subjects) and with a positive control subject (a pool of cervicovaginal lavage fluid specimens or serum from 5 exposed, uninfected persons with previous positive results for IgA to gp41). Each sample was defined as positive and titered when the optical density (OD) value of a specific dilution of the sample showed an OD value similar to that of a pool of negative control subjects.
Statistical analysis. Quantitative data were compared between day 0 and 90 with a Student t test for paired samples in variables with normal distribution and similar variances, or with the Wilcoxon matched-pairs test for variables without normal distribution. To compare variables among highly HIVexposed, uninfected individuals, HIV-infected persons, and low-risk seronegative individuals, we used analysis of variance for variables with normal distribution and similar variances, and the Mann-Whitney U test for variables with nonnormal distribution. Spearman rank-order correlations were performed on quantitative data. Each of the pairwise comparisons used a 2-sided significance level of , adjusted for the number P p .05 of comparisons.
RESULTS
Clinical and epidemiological characteristics of heterosexual couples.
Highly HIV-exposed, uninfected partners had a median age of 33 years (range, 21-55 years), and 16 (76%) were male. The median period of unprotected sex with the partner was 36 months (range, 12-180 months). The median number of episodes of unprotected sexual intercourse in the 3 months prior to day 0 (day of first scheduled visit and blood extraction) /L) and a median of 267 cells ϫ 10 6 /L (range, 12-598 cells ϫ 10 6 /L), respectively. The median day 0 PVL and peak PVL in the HIV-1-infected partners were 24,700 copies/mL (range, 3180-576,000 copies/ mL) and a median of 111,500 copies/mL (range, 4500 to 11,000,000 copies/mL), respectively. Table 1 summarizes the clinical and epidemiological characteristics of heterosexual couples. Heterozygous D32 deletion in the CCR5 gene was observed in 5 highly HIV-exposed, uninfected and 3 HIV-1-infected individuals (table 1) . Plasma HIV-1 RNA levels were repeatedly negative in highly HIV-exposed, uninfected individuals.
At day 90, a total of 10 couples (couples 1, 2, 3, 5, 9, 11, 12, 13, 14, and 20) reported regular use of condoms during their sexual intercourse after day 0. Immunological and microbiological tests were repeated in this group; the rest of the couples were excluded, because they reported that the continued having unprotected sexual intercourse. Nine of 10 HIV-1-infected partners were receiving antiretroviral therapy for at least 3 months (except the patient in couple 2), and 8 of 10 patients had an undetectable PVL level at day 90 (except the patient in couple 2 and the patient in couple 5, who had 2240 and 785 copies/mL, respectively).
Lymphocyte subsets and lymphoproliferative responses to pokeweed mitogens and recall antigens. Table 3 shows the T lymphocyte subsets and lymphoproliferative responses to pokeweed mitogens and recall antigens in highly HIV-exposed, uninfected individuals; HIV-1-infected individuals; and HIVunexposed, uninfected individuals at day 0. All CD4 + T lymphocyte subsets were significantly different when highly T cells than did HIV-unexposed, uninfected individuals. When the absolute number of these subsets was analyzed, the results were similar (table 4) . Most of the CD8 + T cell subsets also differed between highly HIV-exposed, uninfected and HIV-unexposed, uninfected individuals ( (table 4) . Because D32 deletion in the CCR5 gene has been associated with resistance to HIV infection, we analyzed our data excluding those individuals who were heterozygous. Exclusion of these individuals from our analyses did not change our findings (data not shown). There were no differences in the CCR5 expression When compared with HIV-unexposed, uninfected individuals, highly HIV-exposed, uninfected individuals had a significantly lower SI to pokeweed at day 0 ( ). At day 90 P p .01 there was a significant increase ( ) in lymphoprolifera-P p .05 tive response to pokeweed mitogens in highly HIV-exposed, uninfected individuals (mean [SE], 11 [2.8] at day 0 to 21 [3.8] at day 90 [ ]). There were no significant differences be-P p .05 tween highly HIV-exposed, uninfected subjects; HIV-unexposed, uninfected subjects; and HIV-1-infected subjects in the SIs to tetanus toxoid or cytomegalovirus (table 3) . These SIs showed no change at day 90.
There were significant correlations between the PVL of the HIV-1-infected partner at day 0 and some CD4 + and 8 + T cell subsets and lymphoproliferative responses to pokeweed of highly HIV-exposed, uninfected partners (table 5, + T and CD8 + T lymphocytes. Black column, IFN-g production by CD4+ T cells in highly HIV-exposed, uninfected individuals; green column, IFNg production by CD4+ T cells in HIV-1-infected partners; red column, IFN-g production by CD8
+ T cells in highly HIV-exposed, uninfected individuals; blue column, IFN-g production by CD8+ in HIV-1-infected partners; dashed line, cutoff for positive IFN-g production у0.02% of cells.
B, CD8
+ T cell responses measured by ELISPOT. Red column, Highly HIVexposed, uninfected individuals; blue column, HIV-1 infected partners. C, Anti-gp41 HIV-1-specific IgA was measured in cervicovaginal lavage fluid specimens. Blue column, Female HIV-1-infected partner ( ). None n p 16 of the 5 highly HIV-exposed, uninfected women had detectable titers. SFC, spot-forming cells.
against HIV recombinant proteins were detected in HIV-unexposed, uninfected individuals. There were no significant differences between highly HIV-exposed, uninfected subjects; HIV-unexposed, uninfected subjects; and HIV-1-infected individuals in levels of SI to HIV gp160 antigen and p24 antigen (table 3) . These SIs showed no change at day 90.
Positive responses of HIV-specific intracellular IFN-g production by CD4 + T and CD8 + T lymphocytes were detected in 1 of 21 (couple 9) and 4 of 21 (couples 2, 8, 9, and 21) of highly HIV-exposed, uninfected individuals, respectively. HIV-1-infected partners had positive results in 6 of 21 (couples 5, 9, 11, 12, 13, and 17) and 14 of 21 (couples 3, 6, 7, 8, 9, 10, 11, 12, 13, 16, 17, 18, 19, and 20) . (comparison with highly HIV-exposed, uninfected individuals: and , P p .18 P p .001 respectively) ( figure 2A) . These results showed no change at day 90 (data not shown). No measurements were performed in HIV-unexposed, uninfected individuals.
ELISPOT assays were only performed in 20 serodiscordant couples because of lack of cell availability in couple 17. At day 0, a total of 13 of 20 HIV-1-infected partners showed moderate to strong CD8 + T cell responses. Only 2 of the highly HIV- (defined as the number of peptides recognized per patient) was 2 peptides (range, 1-10). ELISPOT assays were only performed for 6 seronegative control subjects because of lack of cell availability. Results showed no positive response against HLAmatched HIV peptides tested in any of the HIV-unexposed, uninfected controls we tested. The background was lower than 20 sfc/10 6 PBMCs.
Anti-gp41 HIV-1-specific IgA was measured in serum and cervicovaginal lavage fluid specimens. Highly HIV-exposed, uninfected individuals had low titers of this antibody. Only 8 of 21 serum samples were weak positive (1 of 50) for anti-gp41 (patients 3, 4, 8, 9, 12, 13, 19, and 20) , whereas all HIV-1-infected patients had a titer of at least 1/1350. None of the 5 highly HIV-exposed, uninfected women had detectable titers in cervicovaginal lavage fluid specimens, while 8 of 16 HIV-1-infected patients had a titer of at least of 1/50 (3 patients [3, 10, 13] had a titer of 1/50, and 5 patients [8, 12, 15, 18, and 19 ] had a titer of 1/150) ( figure 2C ).
There were no significant correlations between the PVL of the HIV-1-infected partner at day 0 and any of the HIV-1-specific responses of highly HIV-exposed, uninfected partners (data not shown).
DISCUSSION
There are 2 alternative hypotheses to explain the immunophenotypic changes observed in highly HIV-exposed, uninfected individuals. First, altered T cell subset distribution patterns in highly HIV-exposed, uninfected individuals could be a consequence of immunogenic challenges during viral exposure [2, 15, [19] [20] [21] [22] . Biasin et al. [19] reported that mucosal and systemic immune activation were present in 9 seronegative women who had multiple episodes of unprotected heterosexual intercourse with their HIV-1-infected heterosexual partners. In the seronegative partners they found a lower level of CD4 [22] and female sex workers [20] .
Conversely, the second hypothesis argues that the changes in immunological parameters observed in high-risk, HIV-exposed, uninfected individuals are a constitutive characteristic and a surrogate marker of genetic or immunological advantage, implying low susceptibility to infection rather than a response to an antigenic exposition. Some investigators have [23] found an increased level of CD8 + T effector cells in seronegative homosexual men who had been highly exposed 10 years before but had changed to low-risk behaviors. In another study, Koning et al. [24] investigated 42 high-risk seronegative individuals and 54 men from the same cohort who were seronegative at the time of analysis but who later became HIV seropositive. Permanently seronegative individuals had lower percentages of activated CD4 + T cells, lower lymphoproliferative responses and higher percentages of HLA DR + CD38 + CD8 T cells than did seroconverters. The authors [24] suggested that the low levels of CD4 + T cell immune activation and low T cell responsiveness may contribute to low HIV susceptibility [25] .
Our study supports the first hypothesis. We found changes in both CD4 + and CD8 + T cells in highly HIV-exposed, uninfected individuals with a lower level of naive and CD28 + T cells and higher level of CD45RA + RO + , CD28 Ϫ CD57 + , HLA-DR + T cells and CD4 + T cells expressing CCR5 and memory CD4 + T cells. Our model for studying serodiscordant couples enables us to correlate PVL of HIV-1-infected partners with immune system changes observed in highly HIV-exposed uninfected individuals, and thus, an attempt can be made to associate the level of viral exposure with differentiation and activation status of T lymphocytes. To our knowledge, this is the first time that a consistent correlation has been found. The changes in memory and activated T cells observed in highly HIV-exposed, uninfected partners were directly correlated with the PVL of the HIV-1-infected partners, whereas the changes in naive and CD28 + T cells observed in highly HIV-exposed uninfected partners were inversely correlated with PVL of the HIV-1-infected partners. In agreement with Koning et al. [24] , we found that highly HIV-exposed, uninfected individuals had lower in vitro proliferation in response to mitogens (pokeweed) than did control subjects. This response was correlated inversely with PVL of the partner and increased close to normal levels (as CD8 + CD28 + T cells did) when HIV exposure was discontinued for 3 months. Decreased lymphoproliferative capacity to pokeweed mitogen in HIV-negative, homosexual subjects exposed to virus, compared with heterosexual control subjects, has been described elsewhere [32] . The observed changes in the stimulation index to pokeweed between day 0 and day 90 could be probably explained by the increase in CD4 + T cells in HIV-infected individuals and by the reduction of certain cellular activation level and the increase in CD4 + CD28 + and naive T cells observed during this period in high risk individuals. Changes in the cytokine milieu after antigen exposure interruption [33] would also probably improve proliferative response to pokeweed mitogen. The benefit of CCR5-D32 heterozygosity on protection against HIV-1 infection has not been well defined [34] [35] [36] [37] . We could not observe differences in the CCR5 expression on the CD4+ T cells between those highly HIV-exposed uninfected individuals with and without the deletion, as previously described [37] . Although we could not exclude the possibility that CCR5-D32 heterozygosity could play a role in resistance to infection in our patients, when we excluded heterozygous individuals from the analysis the findings did not change.
All these data argue against the hypothesis that a constitutive, less reactive immune system results in lower immune activation levels. The data seem to suggest that immunophenotypic changes were a consequence of either HIV-1 exposure or antigenic level, and that immune activation of CD4 + T cells by itself is not sufficient to favor HIV infection, nor is it necessarily an immunological marker of HIV disease, as suggested by Biasin et al. [19] . The down-regulation of CXCR4 expression in both CD4 + and CD8 + T cells observed in highly exposed, uninfected individuals after a period free from viral exposure reinforces this hypothesis. In fact, it has been reported that CXCR4 is downregulated either during T cell differentiation or by lack of proinflamatory or antiviral cytokines [38, 39] .
